Cocaine Abuse
43
1
1
33
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
13 trials with published results (30%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
9.3%
4 terminated out of 43 trials
89.2%
+2.6% vs benchmark
2%
1 trials in Phase 3/4
39%
13 of 33 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 33 completed trials
Clinical Trials (43)
QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428
Low-Intensity Focused Ultrasound for Cocaine Use Disorder
rTMS for Stimulant Use Disorders
Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST)
Dopamine Rhythms in Health and Addiction
Clinical and Atherosclerotic Characteristics of Patients With ACS Associated With Cocaine Use
Substance Abuse Pre-Treatment Screening Study
Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study
Effect of rTMS on Neurotrophines Levels in CUD
Long Term Maintenance of Drug Abstinence
The Effect of Self-Forgiveness on Self-Stigma in Addiction.
Galantamine Effects on Cognitive Function in Abstinent Cocaine Users
Progesterone for the Treatment of Cocaine Dependence - 1
Therapeutic Substance Abuse Treatment in Pregnancy - 1
Abstinence-Linked Money Management Multisite
Screening Protocol for Research Participants
Prize Contingency Management for Cocaine-Dependent Methadone Patients
Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8
Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)
Effect of Clonidine on Responses to Imagery Scripts